bioAffinity Technologies, Inc. (BIAF) Operating margin 2022–2025
bioAffinity Technologies, Inc. (BIAF) operating margin by fiscal year — reported operating income divided by reported revenue.
-171.6%FY2025 · since FY2022: -83511.5% → -171.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -171.6% | -75.9 pp |
| FY2024 | -95.6% | +219.2 pp |
| FY2023 | -314.8% | +83196.7 pp |
| FY2022 | -83511.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BIAF financial trends
BIAF RevenueBIAF Net incomeBIAF Net marginBIAF Gross profitBIAF Gross marginBIAF Operating incomeBIAF Operating cash flowBIAF Free cash flowBIAF Capital expendituresBIAF Return on equityBIAF Stock buybacksBIAF Dividends paidBIAF Total assetsBIAF Total liabilitiesBIAF Shareholders’ equityBIAF overview →